Skip to main content

Baby product company Owlet’s stock sinks after FDA warning letter says it didn’t get proper approval for flagship Smart Sock product

Owlet says it will work with the FDA to resolve the issue, which says the company is in violation of the FDA's rules regarding the marketing of its Smart Sock product
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.